Yingmin Ma

Yingmin Ma

Auto-generated profile, based on publicly available information

Yingmin Ma

Department of Respiratory and Critical Care Medicine, Beijing You'An Hospital, Capital Medical University, Beijing 100069, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in Journal of Infection
Verified
Journal Article
Closed access
YGYuan Gao
Yuan Gao
ZLZujin Luo
Zujin Luo
SRShan Ren
Shan Ren
ZDZhonghui Duan
Zhonghui Duan
YHYing Han
Ying Han
YMYingmin Ma
Yingmin Ma

27 May 2020 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
ZLZujin Luo
Zujin Luo
LYLiu Yang
Liu Yang
SLSijie Liu
Sijie Liu
YHYuhan Hu
Yuhan Hu
ZCZhixin Cao
Zhixin Cao
YMYingmin Ma
Yingmin Ma

1 September 2018 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
ZLZujin Luo
Zujin Luo
YZYinyin Zheng
Yinyin Zheng
LYLiu Yang
Liu Yang
SLSijie Liu
Sijie Liu
JZJian Zhu
Jian Zhu
YMYingmin Ma
Yingmin Ma
Background: To assess the usefulness of the neutrophil/lymphocyte ratio (NLR), a marker of inflammation and/or stress, for predicting weaning failure in patients receiving invasive mechanical ventilation (IMV), compared to levels of leukocytes and C-reactive protein (CRP). Methods: This observational prospective cohort study was conducted from July 2013 to December 2016 in an intensive care unit in China, enrolling 269 consecutive patients receiving IMV. Patients underwent a spontaneous breathing trial (SBT) if they were ready to wean, and underwent extubation if they passed the SBT. The evaluated markers were measured immediately prior to SBT, and compared between weaning-failure and weaning-success patients. Receiver-operating characteristic (ROC) curve and logistic regression analyses were used to evaluate the ability of these markers to predict weaning failure. Results: In all, 94 (34.9%) patients failed the weaning process (66 failed SBT and 28 presented with post-extubation respiratory distress). NLR was a better predictor of failure (area under the ROC curve, 0.69; 95% CI, 0.62–0.76) than leukocyte levels (0.60, 0.53–0.67) and CRP values (0.58, 0.51–0.65). NLR >11, leukocyte counts >10.5×109/L, and CRP >58 mg/L prior to weaning had the best combination of sensitivity (73%, 64%, and 63%, respectively), specificity (59%, 55%, and 63%), positive predictive value (49%, 43%, and 48%), negative predictive value (81%, 74%, and 76%), and diagnostic accuracy (64%, 58%, and 63%) for predicting weaning failure. However, only NLR >11 (odds ratio, 5.91; 95% CI, 3.08–11.33; P<0.001) was an independent predictor of weaning failure in the adjusted logistic regression model. Conclusions: NLR may be a useful marker for predicting weaning failure, and weaning at NLR >11 might be considered with caution. Further study with a larger sample size and with weaning outcome as a variable of concern is warranted. Trial registration: ClinicalTrials.gov identifier: NCT02981589.

3 August 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
ZLZujin Luo
Zujin Luo
SLShunli Li
Shunli Li
NLNan Li
Nan Li
YLYichong Li
Yichong Li
YZYing Zhang
Ying Zhang
YMYingmin Ma
Yingmin Ma
In response to coronavirus disease 2019 (COVID-19), strict public health measures were implemented, and medical resources were enhanced to isolate and treat infected patients.1 Yet little is known about whether other types of hospital visits have been affected,2 especially visits for infectious diseases. We explored changes in pediatric outpatient visits for Chinese notifiable infectious diseases acquired through droplet transmission, contact transmission, or both during Beijing’s COVID-19 outbreak.

22 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WZWenliang Zhai
Wenliang Zhai
ZLZujin Luo
Zujin Luo
YZYue Zheng
Yue Zheng
DDDawei Dong
Dawei Dong
EWEndong Wu
Endong Wu
YMYingmin Ma
Yingmin Ma
This study compared the differences in the clinical manifestations, treatment courses and clinical turnover between mild and moderate coronavirus disease 2019 (COVID-19). Clinical data of the patients with imported COVID-19 admitted to Beijing Xiaotangshan Designated Hospital between March 15 and April 30, 2020, were retrospectively analysed. A total of 53 COVID-19 patients were included, with 21 mild and 32 moderate cases. Compared with the mild group, the moderate group showed significant differences in breathing frequency, lymphocyte count, neutrophil percentage, neutrophil/lymphocyte ratio, procalcitonin, C-reactive protein, and dynamic erythrocyte sedimentation rate. In the moderate group, 87.5% exhibited ground-glass opacities, 14% exhibited consolidative opacities, 53.1% exhibited local lesions and 68.8% exhibited unilateral lesions. The proportion of patients who received antiviral or antibiotic treatment in the moderate group was higher than that in the mild group, and the number of cases that progressed to severe disease in the moderate group was also significantly higher (18.7% vs. 0%, p = 0.035). Compared with patients with mild COVID-19, those with moderate COVID-19 exhibited more noticeable inflammatory reactions, more severe pulmonary imaging manifestations and earlier expression of protective antibodies. The overall turnover of the moderate cases was poorer than that of the mild cases.

2 March 2021 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
ZLZujin Luo
Zujin Luo
YZYi Zhang
Yi Zhang
YZYue Zheng
Yue Zheng
CMC Raina MacIntyre
C Raina MacIntyre
YLYing Liang
Ying Liang
YMYingmin Ma
Yingmin Ma
A surge in the number of international arrivals awaiting coronavirus disease 2019 (COVID-19) screening overwhelmed health-care workers and depleted medical resources in designated hospitals in Beijing, China in March 2020. The People’s Government of Beijing Municipality therefore issued a policy which required the mandatory transfer of all asymptomatic passengers arriving from a foreign country to designated quarantine hotels, and the transfer of passengers with fever or respiratory symptoms to designated hospitals. Xiaotangshan Designated Hospital, a severe acute respiratory syndrome hospital in 2003, was rapidly renovated and put into operation with the main tasks of screening and isolating symptomatic international arrivals at Beijing Capital International Airport, providing basic medical care for mild to moderate COVID-19-positive cases, and rapidly referring severe to critical COVID-19-positive cases to higher-level hospitals. During the month-long period of its operation, 2171 passengers were screened and 53 were confirmed as having COVID-19 (six severe to critical). We describe how the use of Xiaotangshan Designated Hospital in this way enabled the efficient grouping and assessment of passengers arriving from a foreign country, the provision of optimal patient care without compromising public safety and the prioritization of critically ill patients requiring life-saving treatment. The designated hospital is a successful example of the World Health Organization’s recommendation to renovate existing medical infrastructures to improve the COVID-19 response capacity. The flexible design of Xiaotangshan Designated Hospital means that it can be repurposed and reopened at any time to respond to the changing pandemic conditions.